Italy sanctions use of ozone to combat Covid-19
ITALY AHEAD IN RESEARCH, ISS AUTHORIZES USE OF OXYGEN-OZONOOzone therapy can be used to treat people who tested positive at Covid-19.
In a letter sent on 24 March to the Scientific Society of Oxygen Ozono Therapy (SIOOT), the Scientific Secretariat of the President of the Higher Institute of Health (ISS) authorizes the use of ozone therapy for the treatment of people who have tested positive to Covid-19.
It is written in the letter that the proposal of the SIOOT protocol for the possible use of Oxygen Ozono Therapy 'in the treatment of interstitial coronavirus pneumonia has been carefully evaluated by some EXPERTS of the ISS'.
"The actual data available with respect to the proposed indication," the letter continues, "is essentially a demonstration of the effectiveness of ozone in killing the SARS virus in monkey cells, and in the clinical experience of the benefit patients with bronchopneumonia."
After assessing possible investigations, the letter signed by Dr Luigi Bertinato, Head of the President's Scientific Secretariat, states that since the proposal to use ozone oxygen "is supported by expert clinical centers in the treatment of viral pneumonia, the Higher Institute of Health considers it appropriate that the treatment itself can be carried out, after the acquisition of informed consent of the patient, by doctors with specific experience and with the availability of appropriate instrumentation, as described in the protocol itself.'
In the past, the Superior Council of Health had also been involved in gathering knowledge on the issue related to the use of oxygen-ozone therapy.
In a letter from the Ministry of Health – sent to the Regional and Provincial Assessors of Health, to the command of the N.A.S. Carabinieri in Rome and to the Government Commissioners in the Regions and Provinces – it is written that "The Superior Council of Health, in the session of the 23rd In July 1992, it carried out a review of national and international literature on the subject and, in particular, some of the most recent scientific work that has appeared in Medline-accessible journals.'
The letter reiterates that 'antibacterial and antiviral activity of ozone oxygen treatment in relation to blood used for transfusion and blood products has been established'.
In applying for authorisation to use oxygen-ozone therapy, SIOOT recalled that:
- According to the results of an experiment conducted in China in the national laboratory P3 led by Professor Li Zelin, ozone has proven effective in killing the inoculated SARS virus on green monkey kidney cells, achieving a kill rate of 99.22%.
- The virus discovered in Wuhan and the SARS virus both belong to the coronavirus strain. Researchers found that Covid-19 is 80% similar to the SARS virus. It is therefore reasonable to expect ozone to be equally effective in the prevention and control of the new coronavirus.
- SIOOT doctors treated many patients with bronchopulmonary with Oxygen Ozono Therapy SIOOT. The results of ozone therapy were excellent. The duration of the disease was reduced and patients were shown to have a rapid recovery of hypoxia and the radiological picture. Moreover, the practice with ozone oxygen proposed by SIOOT is not incompatible with other drug therapies.
SIOOT has reported that, to date, at least ten hospital centres are already using ozone oxygen in the care of Covid-19 patients. Hospitals are located in Piedmont, Lombardy, Emilia-Romagna, Veneto and Lazio.
In this regard, SIOOT has committed to communicate within 40 days to the Higher Institute of Health the first clinical results from hospitals that are practicing ozone therapy.